# StandardAero, Inc.: financial statements, quarterly

SARO · NYSE · CIK 2025410 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/saro.md) · [Financials](/companies/saro/financials.md) · [Filings](/companies/saro/filings.md) · [Insiders](/companies/saro/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/saro/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,099](/filings/0000950170-24-126486.md) | [1,158 d](/filings/0001193125-26-072618.md) | [1,236](/filings/0000950170-25-070386.md) | [1,347](/filings/0001193125-25-180157.md) | [1,245](/filings/0001193125-25-274305.md) | [1,410 d](/filings/0001193125-26-072618.md) | [1,436](/filings/0001193125-26-212553.md) | [1,529](/filings/0002025410-26-000009.md) | [1,498](/filings/0001193125-25-274305.md) | [1,600 d](/filings/0001193125-26-072618.md) | [1,627](/filings/0001193125-26-212553.md) | [1,600](/filings/0002025410-26-000009.md) |
| Cost of revenue | $m | [948](/filings/0000950170-24-126486.md) | [1,000 d](/filings/0001193125-26-072618.md) | [1,054](/filings/0000950170-25-070386.md) | [1,163](/filings/0001193125-25-180157.md) | [1,058](/filings/0001193125-25-274305.md) | [1,208 d](/filings/0001193125-26-072618.md) | [1,218](/filings/0001193125-26-212553.md) | [1,293](/filings/0002025410-26-000009.md) | [1,275](/filings/0001193125-25-274305.md) | [1,380 d](/filings/0001193125-26-072618.md) | [1,387](/filings/0001193125-26-212553.md) | [1,331](/filings/0002025410-26-000009.md) |
| Selling, general and administrative | $m | [53.0](/filings/0000950170-24-126486.md) | [54.5 d](/filings/0001193125-26-072618.md) | [52.6](/filings/0000950170-25-070386.md) | [56.2](/filings/0001193125-25-180157.md) | [62.9](/filings/0001193125-25-274305.md) | [82.3 d](/filings/0001193125-26-072618.md) | [64.5](/filings/0001193125-26-212553.md) | [76.0](/filings/0002025410-26-000009.md) | [60.9](/filings/0001193125-25-274305.md) | [46.3 d](/filings/0001193125-26-072618.md) | [71.9](/filings/0001193125-26-212553.md) | [75.6](/filings/0002025410-26-000009.md) |
| Operating income | $m | [74.8](/filings/0000950170-24-126486.md) | [79.9 d](/filings/0001193125-26-072618.md) | [106](/filings/0000950170-25-070386.md) | [105](/filings/0001193125-25-180157.md) | [98.0](/filings/0001193125-25-274305.md) | [94.6 d](/filings/0001193125-26-072618.md) | [129](/filings/0001193125-26-212553.md) | [136](/filings/0002025410-26-000009.md) | [137](/filings/0001193125-25-274305.md) | [149 d](/filings/0001193125-26-072618.md) | [143](/filings/0001193125-26-212553.md) | [168](/filings/0002025410-26-000009.md) |
| Interest expense | $m | [79.2](/filings/0000950170-24-126486.md) | [79.1 d](/filings/0001193125-26-072618.md) | [77.5](/filings/0000950170-25-070386.md) | [78.1](/filings/0001193125-25-180157.md) | [79.9](/filings/0001193125-25-274305.md) | [47.0 d](/filings/0001193125-26-072618.md) | [43.8](/filings/0001193125-26-212553.md) | [43.8](/filings/0002025410-26-000009.md) | [44.6](/filings/0001193125-25-274305.md) | [42.0 d](/filings/0001193125-26-072618.md) | [38.2](/filings/0001193125-26-212553.md) | [41.3](/filings/0002025410-26-000009.md) |
| Income tax | $m | [(12.6)](/filings/0000950170-24-126486.md) | [5.3 d](/filings/0001193125-26-072618.md) | [16.9](/filings/0000950170-25-070386.md) | [21.0](/filings/0001193125-25-180157.md) | [0.2](/filings/0001193125-25-274305.md) | [32.7 d](/filings/0001193125-26-072618.md) | [22.2](/filings/0001193125-26-212553.md) | [24.0](/filings/0002025410-26-000009.md) | [24.7](/filings/0001193125-25-274305.md) | [28.6 d](/filings/0001193125-26-072618.md) | [25.0](/filings/0001193125-26-212553.md) | [29.9](/filings/0002025410-26-000009.md) |
| Net income | $m | [(17.9)](/filings/0000950170-24-126486.md) | [(4.6) d](/filings/0001193125-26-072618.md) | [3.2](/filings/0001193125-25-274305.md) | [5.4](/filings/0001193125-25-274305.md) | [16.4](/filings/0001193125-25-274305.md) | [(14.1) d](/filings/0001193125-26-072618.md) | [62.9](/filings/0002025410-26-000009.md) | [67.7](/filings/0002025410-26-000009.md) | [68.1](/filings/0001193125-25-274305.md) | [78.6 d](/filings/0001193125-26-072618.md) | [79.9](/filings/0002025410-26-000009.md) | [97.3](/filings/0002025410-26-000009.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0000950170-24-126486.md) | not reported | [0.02](/filings/0001193125-25-180157.md) | [0.02](/filings/0001193125-25-180157.md) | [0.06](/filings/0001193125-25-274305.md) | not reported | [0.19](/filings/0001193125-26-212553.md) | [0.20](/filings/0002025410-26-000009.md) | [0.20](/filings/0001193125-25-274305.md) | not reported | [0.24](/filings/0001193125-26-212553.md) | [0.29](/filings/0002025410-26-000009.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0000950170-24-126486.md) | not reported | [0.01](/filings/0000950170-25-070386.md) | [0.02](/filings/0001193125-25-180157.md) | [0.06](/filings/0001193125-25-274305.md) | not reported | [0.19](/filings/0001193125-26-212553.md) | [0.21](/filings/0002025410-26-000009.md) | [0.21](/filings/0001193125-25-274305.md) | not reported | [0.24](/filings/0001193125-26-212553.md) | [0.30](/filings/0002025410-26-000009.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [58.0](/filings/0000950170-25-037939.md) | not reported | not reported | [51.3](/filings/0000950170-24-126486.md) | [103](/filings/0001193125-26-072618.md) | [141](/filings/0000950170-25-070386.md) | [91.5](/filings/0001193125-25-180157.md) | [97.5](/filings/0001193125-25-274305.md) | [290](/filings/0002025410-26-000009.md) | [89.2](/filings/0001193125-26-212553.md) | [179](/filings/0002025410-26-000009.md) |
| Current assets | $m | not reported | [2,136](/filings/0000950170-25-037939.md) | not reported | not reported | [2,359](/filings/0000950170-24-126486.md) | [2,485](/filings/0001193125-26-072618.md) | [2,795](/filings/0000950170-25-070386.md) | [2,769](/filings/0001193125-25-180157.md) | [2,961](/filings/0001193125-25-274305.md) | [2,896](/filings/0002025410-26-000009.md) | [3,065](/filings/0001193125-26-212553.md) | [3,029](/filings/0002025410-26-000009.md) |
| Total assets | $m | not reported | [5,759](/filings/0000950170-25-037939.md) | not reported | not reported | [6,059](/filings/0000950170-24-126486.md) | [6,214](/filings/0001193125-26-072618.md) | [6,496](/filings/0000950170-25-070386.md) | [6,483](/filings/0001193125-25-180157.md) | [6,649](/filings/0001193125-25-274305.md) | [6,557](/filings/0002025410-26-000009.md) | [6,705](/filings/0001193125-26-212553.md) | [6,850](/filings/0002025410-26-000009.md) |
| Current liabilities | $m | not reported | [1,069](/filings/0000950170-25-037939.md) | not reported | not reported | [1,119](/filings/0000950170-24-126486.md) | [1,274](/filings/0001193125-26-072618.md) | [1,396](/filings/0000950170-25-070386.md) | [1,285](/filings/0001193125-25-180157.md) | [1,359](/filings/0001193125-25-274305.md) | [1,316](/filings/0002025410-26-000009.md) | [1,444](/filings/0001193125-26-212553.md) | [1,419](/filings/0002025410-26-000009.md) |
| Total liabilities | $m | not reported | [4,613](/filings/0000950170-25-037939.md) | not reported | not reported | [4,895](/filings/0000950170-24-126486.md) | [3,840](/filings/0001193125-26-072618.md) | [4,058](/filings/0000950170-25-070386.md) | [3,969](/filings/0001193125-25-180157.md) | [4,064](/filings/0001193125-25-274305.md) | [3,890](/filings/0002025410-26-000009.md) | [4,015](/filings/0001193125-26-212553.md) | [4,097](/filings/0002025410-26-000009.md) |
| Long-term debt | $m | not reported | [3,172](/filings/0000950170-25-037939.md) | not reported | not reported | [3,391](/filings/0000950170-24-126486.md) | [2,208](/filings/0001193125-26-072618.md) | [2,314](/filings/0000950170-25-070386.md) | [2,295](/filings/0001193125-25-180157.md) | [2,305](/filings/0001193125-25-274305.md) | [2,191](/filings/0002025410-26-000009.md) | [2,186](/filings/0001193125-26-212553.md) | [2,302](/filings/0002025410-26-000009.md) |
| Current portion of debt | $m | not reported | [26.7](/filings/0000950170-25-037939.md) | not reported | not reported | [30.6](/filings/0000950170-24-126486.md) | [23.4](/filings/0001193125-26-072618.md) | [23.5](/filings/0000950170-25-070386.md) | [23.5](/filings/0001193125-25-180157.md) | [23.5](/filings/0001193125-25-274305.md) | [23.4](/filings/0002025410-26-000009.md) | [23.3](/filings/0001193125-26-212553.md) | [23.3](/filings/0002025410-26-000009.md) |
| Shareholders' equity | $m | [1,174](/filings/0000950170-24-126486.md) | [1,147](/filings/0001193125-26-072618.md) | [1,153](/filings/0001193125-25-274305.md) | [1,159](/filings/0001193125-25-274305.md) | [1,164](/filings/0001193125-25-274305.md) | [2,373](/filings/0002025410-26-000009.md) | [2,438](/filings/0002025410-26-000009.md) | [2,513](/filings/0002025410-26-000009.md) | [2,585](/filings/0001193125-25-274305.md) | [2,667](/filings/0002025410-26-000009.md) | [2,690](/filings/0002025410-26-000009.md) | [2,753](/filings/0002025410-26-000009.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [164 d](/filings/0001193125-26-072618.md) | [(83.6)](/filings/0000950170-25-070386.md) | [65.4 d](/filings/0001193125-25-180157.md) | [(13.9) d](/filings/0001193125-25-274305.md) | [108 d](/filings/0001193125-26-072618.md) | [(24.0)](/filings/0001193125-26-212553.md) | [2.9 d](/filings/0002025410-26-000009.md) | [14.8 d](/filings/0001193125-25-274305.md) | [323 d](/filings/0001193125-26-072618.md) | [(120)](/filings/0001193125-26-212553.md) | [72.3 d](/filings/0002025410-26-000009.md) |
| Capital expenditure | $m | not reported | [18.5](/filings/0000950170-25-070386.md) | [26.6 d](/filings/0001193125-25-180157.md) | [25.3 d](/filings/0001193125-25-274305.md) | [32.5 d](/filings/0001193125-26-072618.md) | [25.3](/filings/0001193125-26-212553.md) | [21.9 d](/filings/0002025410-26-000009.md) | [19.5 d](/filings/0001193125-25-274305.md) | [15.7 d](/filings/0001193125-26-072618.md) | [15.6](/filings/0001193125-26-212553.md) | [21.1 d](/filings/0002025410-26-000009.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [60.1](/filings/0001193125-26-212553.md) | [40.0 d](/filings/0002025410-26-000009.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [281](/filings/0000950170-24-126486.md) | [0.3](/filings/0000950170-25-070386.md) | [0.3](/filings/0001193125-25-180157.md) | [0.3](/filings/0001193125-25-274305.md) | [0.3](/filings/0001193125-26-212553.md) | [0.3](/filings/0002025410-26-000009.md) | [0.3](/filings/0001193125-25-274305.md) | [0.3](/filings/0001193125-26-212553.md) | [0.3](/filings/0002025410-26-000009.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 330,919,431 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0002025410-26-000009.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.